Europe is poised for change with a recent flurry of activity around medical cannabis reform and legislation, and Portugal, in particular, plays a key role in this expanding market.
The conference will be preceded by a full-day medical course, “Introduction to Endocannabinology and Medical Cannabis,” taking place on Tuesday, 11 February.
With hundreds of attendees, CannX is the ultimate platform for the exchange of high-level scientific knowledge, professional expertise and valuable networking opportunities.
An application will be made to the European Accreditation Council for Continuing Medical Education (EACCME) for CME accreditation of CannX Lisbon. The EACCME is an institution of the European Union of Medical Specialists (UEMS)
The main program includes 3 exciting tracks – Science, Business, and Agriculture.
SCI:
• The Latest in Medical Cannabis Research
• Autoimmune Diseases
• Mental Health Disorders
• Neuroprotection and Neuroregeneration
• Cannabinoids Mechanism of Action
• Medical Grade Cannabis
• Patient Wellbeing – Risk and Side Effect Management
• THC and CBD Interactions
• Dependency
• The Endocannabinoid System as an Emerging Target of Pharmacotherapy
• New Clinical Research on Various Diseases – Dementia, Autism, Diabetes, Tourette’s Syndrome, Gynecological Diseases, Cardiovascular Conditions
BIZ:
• Entering the Pharmaceutical Industry – How to Meet Pharma Standards
• How to Assess the True Value of a Company
• Global Trade – Regulation and Standardization
• Dosage and Delivery Methods
• Digital Health
• Ethical Issues
• How to Regulate Medical Cannabis for the Safety and Satisfaction of Public
• Policy, the Industry and the Patients
AGR:
• Advanced Growing Technologies – Tissue Culture Technologies, Vertical Growing
• Cannabis Farm Management Software
• New developments in Genetics
• Plant Control and Testing: How to Grow Top Quality Crops
Recomendamos que confirme toda a informação junto do promotor oficial deste evento. Por favor contacte-nos se detectar que existe alguma informação incorrecta.
